Delivery Order SPE2DE23D0008-SPE2D626F99F2
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,614.00 by the Defense Logistics Agency's Medical Supply Chain division on December 17, 2025, for Natrelle Inspira SCF 485CC breast implants. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of December 19, 2025, and will be performed in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814.00 fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on November 18, 2025, for Natrelle Inspira SCX 750cc breast implants. The contract, which carries no set-aside designation, is classified as a child order under a larger Indefinite Delivery Vehicle and reflects Allergan's status as a sole-source provider of specialized surgical devices to federal healthcare systems. The delivery order is set to...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical on November 6, 2025, for Natrelle Inspira SSM 405CC breast implants. The contract, which represents a child delivery order under a larger Indefinite Delivery Vehicle (IDV), is scheduled for completion by November 24, 2025, and will be performed at the contractor's facility in Irvine, California. The award carries no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order for Natrelle Inspira SSM 275CC breast implants by the Defense Logistics Agency's Medical Supply Chain division on December 18, 2025. This delivery order, which is a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements, carries an ultimate completion date of January 7, 2026, and will be fulfilled at the contractor's facility in Irvine, California. The contract...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,400.00 for Natrelle Inspira SCX 800cc breast implants by the Defense Logistics Agency's Medical Supply Chain division. The contract was awarded on November 25, 2025, with a completion date of November 28, 2025, and utilizes a fixed-price contract structure with economic price adjustment. The delivery order carries no set-aside designation and represents a child contract under one of Allergan's two...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order on January 2, 2026, for Natrelle Inspira SSM 255cc breast implants, with a completion date of January 15, 2026. The contract was issued without set-aside designation and is funded through the Medical Supply Chain division of the Defense Logistics Agency. Performance will take place in Irvine, California. This delivery order represents a task order issued under one of Allergan's larger Indefinite...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,092.00 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division for Inspira SRLP 205CC breast implants. The award, made on September 11, 2025, with an ultimate completion date of September 22, 2025, represents a child delivery order under one of Allergan's larger Indefinite Delivery Vehicle contracts for Natrelle breast implants and surgical devices valued at $13.5 million. The contract utilizes...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D626F99F2Delivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, for Natrelle Inspira SCF 695CC breast implants. The delivery order, which is classified as a child contract, is scheduled for completion by January 13, 2026, and was awarded without any set-aside designation. This award falls under Allergan's larger Indefinite Delivery/Indefinite Quantity (IDV) vehicle—specifically the $13.5 million Natrelle breast implants and surgical devices IDV established on December 8, 2022—which enables the electronic ordering and fulfillment of breast implant products across Department of Defense research centers, hospitals, and clinics. The delivery order supports reconstructive and aesthetic surgical procedures at military treatment facilities and represents continued procurement of specialized medical devices that Allergan supplies as a sole-source provider to federal healthcare systems. As a fixed-price contract with economic price adjustment, the award maintains pricing stability while allowing for adjustments based on specified economic factors. The condensed completion timeline of six days from award to ultimate completion date reflects the expedited nature of medical supply fulfillment for active military and defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/6/26 |